1
|
Satitsri S and Muanprasat C: Chitin and
chitosan derivatives as biomaterial resources for biological and
biomedical applications. Molecules. 25(5961)2020.PubMed/NCBI View Article : Google Scholar
|
2
|
Guan G, Azad MAK, Lin Y, Kim SW, Tian Y,
Liu G and Wang H: Biological effects and applications of chitosan
and chito-oligosaccharides. Front Physiol. 10(516)2019.PubMed/NCBI View Article : Google Scholar
|
3
|
Shahbaz U: Chitin, characteristic,
sources, and biomedical application. Curr Pharm Biotechnol.
21:1433–1443. 2020.PubMed/NCBI View Article : Google Scholar
|
4
|
Wang W, Meng Q, Li Q, Liu J, Zhou M, Jin Z
and Zhao K: Chitosan derivatives and their application in
biomedicine. Int J Mol Sci. 21(487)2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Naveed M, Phil L, Sohail M, Hasnat M, Baig
MMFA, Ihsan AU, Shumzaid M, Kakar MU, Mehmood Khan T, Akabar MD, et
al: Chitosan oligosaccharide (COS): An overview. Int J Biol
Macromol. 129:827–843. 2019.PubMed/NCBI View Article : Google Scholar
|
6
|
Fan Z, Wang L, Qin Y and Li P: Activity of
chitin/chitosan/chitosan oligosaccharide against plant pathogenic
nematodes and potential modes of application in agriculture: A
review. Carbohydr Polym. 306(120592)2023.PubMed/NCBI View Article : Google Scholar
|
7
|
Zheng J, Cheng G, Li Q, Jiao S, Feng C,
Zhao X, Yin H, Du Y and Liu H: Chitin oligosaccharide modulates gut
microbiota and attenuates high-fat-diet-induced metabolic syndrome
in mice. Mar Drugs. 16(66)2018.PubMed/NCBI View Article : Google Scholar
|
8
|
Yuan X, Zheng J, Jiao S, Cheng G, Feng C,
Du Y and Liu H: A review on the preparation of chitosan
oligosaccharides and application to human health, animal husbandry
and agricultural production. Carbohydr Polym. 220:60–70.
2019.PubMed/NCBI View Article : Google Scholar
|
9
|
Lan R, Chang Q, Wei L and Zhao Z: The
protect effects of chitosan oligosaccharides on intestinal
integrity by regulating oxidative status and inflammation under
oxidative stress. Mar Drugs. 19(57)2021.PubMed/NCBI View Article : Google Scholar
|
10
|
Hao C, Wang W, Wang S, Zhang L and Guo Y:
An overview of the protective effects of chitosan and acetylated
chitosan oligosaccharides against neuronal disorders. Mar Drugs.
15(89)2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Zhai X, Yuan S, Yang X, Zou P, Shao Y, Abd
El-Aty AM, Hacımüftüoğlu A and Wang J: Growth-inhibition of S180
residual-tumor by combination of cyclophosphamide and chitosan
oligosaccharides in vivo. Life Sci. 202:21–27. 2018.PubMed/NCBI View Article : Google Scholar
|
12
|
Shagdarova B, Konovalova M, Varlamov V and
Svirshchevskaya E: Anti-obesity effects of chitosan and its
derivatives. Polymers (Basel). 15(3967)2023.PubMed/NCBI View Article : Google Scholar
|
13
|
Hao C, Han M, Wang W, Yang C, Wang J, Guo
Y, Xu T, Zhang L and Li C: The neuroprotective effects of
peracetylated chitosan oligosaccharides against β-amyloid-induced
cognitive deficits in rats. Mar Life Sci Technol. 5:211–222.
2023.PubMed/NCBI View Article : Google Scholar
|
14
|
Wang B, Wang L, Qu Y, Lu J and Xia W:
Chitosan oligosaccharides exert neuroprotective effects via
modulating the PI3K/Akt/Bcl-2 pathway in a Parkinsonian model. Food
Funct. 13:5838–5853. 2022.PubMed/NCBI View Article : Google Scholar
|
15
|
He N, Wang S, Lv Z, Zhao W and Li S: Low
molecular weight chitosan oligosaccharides (LMW-COSs) prevent
obesity-related metabolic abnormalities in association with the
modification of gut microbiota in high-fat diet (HFD)-fed mice.
Food Funct. 11:9947–9959. 2020.PubMed/NCBI View Article : Google Scholar
|
16
|
Patoulias D, Stavropoulos K, Imprialos K,
Athyros V, Grassos H, Doumas M and Faselis C: Inflammatory markers
in cardiovascular disease; lessons learned and future perspectives.
Curr Vasc Pharmacol. 19:323–342. 2021.PubMed/NCBI View Article : Google Scholar
|
17
|
Yu Y, Luo T, Liu S, Song G, Han J, Wang Y,
Yao S, Feng L and Qin S: Chitosan oligosaccharides attenuate
atherosclerosis and decrease non-HDL in ApoE-/- mice. J Atheroscler
Thromb. 22:926–941. 2015.PubMed/NCBI View Article : Google Scholar
|
18
|
Yu Y, Wang S, Chen X, Gao Z, Dai K, Wang J
and Liu C: Sulfated oligosaccharide activates endothelial Notch for
inducing macrophage-associated arteriogenesis to treat ischemic
diseases. Proc Natl Acad Sci USA. 120(e2307480120)2023.PubMed/NCBI View Article : Google Scholar
|
19
|
Guo C, Zhang Y, Ling T, Zhao C, Li Y, Geng
M, Gai S, Qi W, Luo X, Chen L, et al: Chitosan oligosaccharides
alleviate colitis by regulating intestinal microbiota and
PPARγ/SIRT1-Mediated NF-κB pathway. Mar Drugs.
20(96)2022.PubMed/NCBI View Article : Google Scholar
|
20
|
Zhang P, Li T, Wu X, Nice EC, Huang C and
Zhang Y: Oxidative stress and diabetes: Antioxidative strategies.
Front Med. 14:583–600. 2020.PubMed/NCBI View Article : Google Scholar
|
21
|
Batty M, Bennett MR and Yu E: The role of
oxidative stress in atherosclerosis. Cells. 11(3843)2022.PubMed/NCBI View Article : Google Scholar
|
22
|
Hayes JD, Dinkova-Kostova AT and Tew KD:
Oxidative stress in cancer. Cancer Cell. 38:167–197.
2020.PubMed/NCBI View Article : Google Scholar
|
23
|
Jomova K, Raptova R, Alomar SY, Alwasel
SH, Nepovimova E, Kuca K and Valko M: Reactive oxygen species,
toxicity, oxidative stress, and antioxidants: Chronic diseases and
aging. Arch Toxicol. 97:2499–2574. 2023.PubMed/NCBI View Article : Google Scholar
|
24
|
Sies H, Berndt C and Jones DP: Oxidative
stress. Annu Rev Biochem. 86:715–748. 2017.PubMed/NCBI View Article : Google Scholar
|
25
|
Steven S, Frenis K, Oelze M, Kalinovic S,
Kuntic M, Bayo Jimenez MT, Vujacic-Mirski K, Helmstädter J,
Kröller-Schön S, Münzel T and Daiber A: Vascular inflammation and
oxidative stress: Major triggers for cardiovascular disease. Oxid
Med Cell Longev. 2019(7092151)2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Senoner T and Dichtl W: Oxidative stress
in cardiovascular diseases: Still a therapeutic target? Nutrients.
11(2090)2019.PubMed/NCBI View Article : Google Scholar
|
27
|
Zhu H, Jia Z, Zhang L, Yamamoto M, Misra
HP, Trush MA and Li Y: Antioxidants and phase 2 enzymes in
macrophages: Regulation by Nrf2 signaling and protection against
oxidative and electrophilic stress. Exp Biol Med (Maywood).
233:463–474. 2008.PubMed/NCBI View Article : Google Scholar
|
28
|
Grom AA and Mellins ED: Macrophage
activation syndrome: Advances towards understanding pathogenesis.
Curr Opin Rheumatol. 22:561–566. 2010.PubMed/NCBI View Article : Google Scholar
|
29
|
Li P, Hao Z, Wu J, Ma C, Xu Y, Li J, Lan
R, Zhu B, Ren P, Fan D and Sun S: Comparative proteomic analysis of
polarized human THP-1 and mouse RAW264.7 macrophages. Front
Immunol. 12(700009)2021.PubMed/NCBI View Article : Google Scholar
|
30
|
Mei QX, Hu JH, Huang ZH, Fan JJ, Huang CL,
Lu YY, Wang XP and Zeng Y: Pretreatment with chitosan
oligosaccharides attenuate experimental severe acute pancreatitis
via inhibiting oxidative stress and modulating intestinal
homeostasis. Acta Pharmacol Sin. 42:942–953. 2021.PubMed/NCBI View Article : Google Scholar
|
31
|
Yang Z, Hong W, Zheng K, Feng J, Hu C, Tan
J, Zhong Z and Zheng Y: Chitosan oligosaccharides alleviate
H2O2-stimulated granulosa cell damage via
HIF-1α signaling pathway. Oxid Med Cell Longev.
2022(4247042)2022.PubMed/NCBI View Article : Google Scholar
|
32
|
Wu J, Xu Y, Geng Z, Zhou J, Xiong Q, Xu Z,
Li H and Han Y: Chitosan oligosaccharide alleviates renal fibrosis
through reducing oxidative stress damage and regulating
TGF-β1/Smads pathway. Sci Rep. 12(19160)2022.PubMed/NCBI View Article : Google Scholar
|
33
|
Wang Y and Xiong Y, Zhang A, Zhao N, Zhang
J, Zhao D, Yu Z, Xu N, Yin Y, Luan X and Xiong Y: Oligosaccharide
attenuates aging-related liver dysfunction by activating Nrf2
antioxidant signaling. Food Sci Nutr. 8:3872–3881. 2020.PubMed/NCBI View Article : Google Scholar
|
34
|
Hao W, Li K, Ge X, Yang H, Xu C, Liu S, Yu
H, Li P and Xing R: The effect of N-acetylation on the
anti-inflammatory activity of chitooligosaccharides and its
potential for relieving endotoxemia. Int J Mol Sci.
23(8205)2022.PubMed/NCBI View Article : Google Scholar
|
35
|
Abd El-Hack ME, El-Saadony MT, Shafi ME,
Zabermawi NM, Arif M, Batiha GE, Khafaga AF, Abd El-Hakim YM and
Al-Sagheer AA: Antimicrobial and antioxidant properties of chitosan
and its derivatives and their applications: A review. Int J Biol
Macromol. 164:2726–2744. 2020.PubMed/NCBI View Article : Google Scholar
|
36
|
Zheng J, Yuan X, Cheng G, Jiao S, Feng C,
Zhao X, Yin H, Du Y and Liu H: Chitosan oligosaccharides improve
the disturbance in glucose metabolism and reverse the dysbiosis of
gut microbiota in diabetic mice. Carbohydr Polym. 190:77–86.
2018.PubMed/NCBI View Article : Google Scholar
|
37
|
Xu Q, Liu M, Liu Q, Wang W, Du Y and Yin
H: The inhibition of LPS-induced inflammation in RAW264.7
macrophages via the PI3K/Akt pathway by highly N-acetylated
chitooligosaccharide. Carbohydr Polym. 174:1138–1143.
2017.PubMed/NCBI View Article : Google Scholar
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
39
|
Wang H, Ge W, Jiang W, Li D and Ju X:
SRPK1-siRNA suppresses K562 cell growth and induces apoptosis via
the PARP-caspase3 pathway. Mol Med Rep. 17:2070–2076.
2018.PubMed/NCBI View Article : Google Scholar
|
40
|
Smith AJO, Ball SS, Bowater RP and
Wormstone IM: PARP-1 inhibition influences the oxidative stress
response of the human lens. Redox Biol. 8:354–362. 2016.PubMed/NCBI View Article : Google Scholar
|
41
|
Singh R, Letai A and Sarosiek K:
Regulation of apoptosis in health and disease: The balancing act of
BCL-2 family proteins. Nat Rev Mol Cell Biol. 20:175–193.
2019.PubMed/NCBI View Article : Google Scholar
|
42
|
Peña-Blanco A and García-Sáez AJ: Bax, Bak
and beyond-mitochondrial performance in apoptosis. FEBS J.
285:416–431. 2018.PubMed/NCBI View Article : Google Scholar
|
43
|
Lan R, Chang Q, An L and Zhao Z: Dietary
supplementation with chitosan oligosaccharides alleviates oxidative
stress in rats challenged with hydrogen peroxide. Animals (Basel).
10(55)2019.PubMed/NCBI View Article : Google Scholar
|
44
|
Marmouzi I, Ezzat SM, Salama MM, Merghany
RM, Attar AM, El-Desoky AM and Mohamed SO: Recent updates in
pharmacological properties of chitooligosaccharides. Biomed Res
Int. 2019(4568039)2019.PubMed/NCBI View Article : Google Scholar
|
45
|
Liu W, Liu Y, Li H and Rodgers GP:
Olfactomedin 4 contributes to hydrogen peroxide-induced NADPH
oxidase activation and apoptosis in mouse neutrophils. Am J Physiol
Cell Physiol. 315:C494–C501. 2018.PubMed/NCBI View Article : Google Scholar
|
46
|
Zhang Y, Ahmad KA, Khan FU, Yan S, Ihsan
AU and Ding Q: Chitosan oligosaccharides prevent
doxorubicin-induced oxidative stress and cardiac apoptosis through
activating p38 and JNK MAPK mediated Nrf2/ARE pathway. Chem Biol
Interact. 305:54–65. 2019.PubMed/NCBI View Article : Google Scholar
|
47
|
Jia P, Yu L, Tao C, Dai G, Zhang Z and Liu
S: Chitosan oligosaccharides protect nucleus pulposus cells from
hydrogen peroxide-induced apoptosis in a rat experimental model.
Biomed Pharmacother. 93:807–815. 2017.PubMed/NCBI View Article : Google Scholar
|
48
|
Zhu L, Li R, Jiao S, Wei J, Yan Y, Wang
ZA, Li J and Du Y: Blood-brain barrier permeable chitosan
oligosaccharides interfere with β-amyloid aggregation and alleviate
β-amyloid protein mediated neurotoxicity and neuroinflammation in a
dose- and degree of polymerization-dependent manner. Mar Drugs.
18(488)2020.PubMed/NCBI View Article : Google Scholar
|
49
|
Abate M, Festa A, Falco M, Lombardi A,
Luce A, Grimaldi A, Zappavigna S, Sperlongano P, Irace C, Caraglia
M and Misso G: Mitochondria as playmakers of apoptosis, autophagy
and senescence. Semin Cell Dev Biol. 98:139–153. 2020.PubMed/NCBI View Article : Google Scholar
|
50
|
Bock FJ and Tait SWG: Mitochondria as
multifaceted regulators of cell death. Nat Rev Mol Cell Biol.
21:85–100. 2020.PubMed/NCBI View Article : Google Scholar
|
51
|
Zheng C, Liu T, Liu H and Wang J: Role of
BCL-2 family proteins in apoptosis and its regulation by nutrients.
Curr Protein Pept Sci. 21:799–806. 2020.PubMed/NCBI View Article : Google Scholar
|
52
|
Henning RJ, Bourgeois M and Harbison RD:
Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors: Mechanisms
of action and role in cardiovascular disorders. Cardiovasc Toxicol.
18:493–506. 2018.PubMed/NCBI View Article : Google Scholar
|
53
|
Huang H, Ouyang Q, Mei K, Liu T, Sun Q,
Liu W and Liu R: Acetylation of SCFD1 regulates SNARE complex
formation and autophagosome-lysosome fusion. Autophagy. 19:189–203.
2023.PubMed/NCBI View Article : Google Scholar
|
54
|
Dong X, Shu L, Zhang J, Yang X, Cheng X,
Zhao X, Qu W, Zhu Q, Shou Y, Peng G, et al: Ogt-mediated
O-GlcNAcylation inhibits astrocytes activation through modulating
NF-κB signaling pathway. J Neuroinflammation.
20(146)2023.PubMed/NCBI View Article : Google Scholar
|